about
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activa...
Read More
3.03
0.15
(5.21%)
5.0M
XNAS Volume
High volume+gain today
XNAS 26 Jun, 2026 5:30 PM (EDT)
Not Eligible
Mid Valuation
Technically Bearish
Agenus Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..